Carroll Financial Associates’s West Pharmaceutical WST Stock Holding History

Carroll Financial Associates’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$44K	Sell	96 -5	-5%	-$2.15K	﹤0.01%	757
2021 Q3	$42K	Buy	101 +3	+3%	+$1.26K	﹤0.01%	794
2021 Q2	$35K	Buy	98 +6	+7%	+$1.98K	﹤0.01%	920
2021 Q1	$25K	Hold	92	–	–	﹤0.01%	961
2020 Q4	$26K	Hold	92	–	–	﹤0.01%	860
2020 Q3	$25K	Sell	92 -261	-74%	-$69.1K	﹤0.01%	811
2020 Q2	$80K	Buy	353 +246	+230%	+$48.3K	0.01%	528
2020 Q1	$16K	Hold	107	–	–	﹤0.01%	837
2019 Q4	$16K	Sell	107 -26	-20%	-$3.79K	﹤0.01%	935
2019 Q3	$18K	Hold	133	–	–	﹤0.01%	861
2019 Q2	$16K	Buy	133 +28	+27%	+$3.31K	﹤0.01%	888
2019 Q1	$11K	Hold	105	–	–	﹤0.01%	928
2018 Q4	$10K	Sell	105 -5	-5%	-$543	﹤0.01%	866
2018 Q3	$13K	Buy	110 +33	+43%	+$3.7K	﹤0.01%	835
2018 Q2	$7K	Hold	77	–	–	﹤0.01%	965
2018 Q1	$6K	Hold	77	–	–	﹤0.01%	993
2017 Q4	$7K	Hold	77	–	–	﹤0.01%	938
2017 Q3	$7K	Hold	77	–	–	﹤0.01%	916
2017 Q2	$7K	Buy	+77	New	+$7.08K	﹤0.01%	919

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carroll Financial Associates's WST Position: Q4 2021 in Review

Carroll Financial Associates reduced its West Pharmaceutical (WST) stake by 5% in Q4 2021, selling an estimated $2.15K and leaving 96 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #757.

Carroll Financial Associates first reported a position in WST in Q2 2017 and has held it in 19 quarters since. The position peaked at $80K in Q2 2020. 731 funds tracked by Wall St. Rank hold WST as of Q4 2021.

Carroll Financial Associates held 96 shares of West Pharmaceutical worth $44K as of Q4 2021.
Carroll Financial Associates sold 5 West Pharmaceutical shares in Q4 2021, an estimated $2.15K.
West Pharmaceutical made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #757 holding.
Carroll Financial Associates first reported a position in West Pharmaceutical in Q2 2017 and has held it in 19 quarters since.
Carroll Financial Associates's West Pharmaceutical position peaked at $80K in Q2 2020.
731 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.